<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>sitagliptin inhibits dipeptidyl peptidase 4 — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>sitagliptin</strong>
  <span class="pred">&mdash;inhibits&rarr;</span>
  <strong>dipeptidyl peptidase 4</strong>
</div>
<div class="entity-id">CHEBI:40237 &nbsp;&middot;&nbsp; UNKNOWN:DPP4</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 63.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 11 citations: <strong>63.00</strong><br><span style="color:#888">1&times; extends (+12.00) &middot; 6&times; supports (+60.00) &middot; 3&times; contradicts (-15.00) &middot; 1&times; applies (+6.00)</span><br>Neighbourhood: 69.13</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1073/pnas.2117089119">10.1073/pnas.2117089119</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS3305">MTBLS3305</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 11 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>6</span><span class="cite-subtotal">&middot; +60.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycylproline — is_metabolite_of → dipeptidyl peptidase 4</span><span class="cite-claim-weight">+10.00</span><a href="../claim/1af181bed665ea9f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycylproline — inhibits → immune response to SARS-CoV-2 vaccination</span><span class="cite-claim-weight">+10.00</span><a href="../claim/cd033208da16f911.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">sitagliptin — treats → COVID-19</span><span class="cite-claim-weight">+10.00</span><a href="../claim/dc8d2665fed4ad5c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">M-CSF — is_biomarker_for → antibody fading in COVID-19 convalescent patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/ff4e0c492b91bd4e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">IL-12p40 — is_biomarker_for → antibody fading in COVID-19 convalescent patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/6becb84d4c74ba92.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain acylcarnitines — is_biomarker_for → antibody fading in COVID-19 convalescent patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/ddc16f508e69e426.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:50px"></span><span>3</span><span class="cite-subtotal">&middot; -15.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycylproline — distinguishes → COVID-19 convalescents with faded antibodies vs. convalescents with antibodies</span><span class="cite-claim-weight">-5.00</span><a href="../claim/6355280f0589601c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycylproline — increases → COVID-19 convalescents with rapidly faded antibodies (CO)</span><span class="cite-claim-weight">-5.00</span><a href="../claim/635ff5b0cb5569ab.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycylproline — decreases → SARS-CoV-2 receptor-binding domain antibody levels</span><span class="cite-claim-weight">-5.00</span><a href="../claim/fac4f9d7f8a1c3af.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:17px"></span><span>1</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">sitagliptin — activates → immune response to SARS-CoV-2 vaccination</span><span class="cite-claim-weight">+12.00</span><a href="../claim/633bff981301e4be.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:17px"></span><span>1</span><span class="cite-subtotal">&middot; +6.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">17-feature panel (6 cytokines + 11 metabolites) — distinguishes → COVID-19 convalescents with faded antibodies vs. convalescents with antibodies</span><span class="cite-claim-weight">+6.00</span><a href="../claim/03682cc565768415.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>be41850aec308b7b</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:40237">CHEBI:40237</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:DPP4">UNKNOWN:DPP4</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
